ARGENT BIOPHARMA LIMITED ASX News

31 October 2024

Quarterly Activities/Appendix 4C Cash Flow Report

Argent BioPharma reports collaboration with SINTEF and voluntary delisting from ASX.

Argent BioPharma Biopharmaceuticals Stock Market News ASX Delisting Corporate Strategy

Posted on: 31/10/2024

29 July 2024

Quarterly Activities/Appendix 4C Cash Flow Report

Argent BioPharma lists on OTCQB and appoints new CFO.

Argent BioPharma OTCQB Listing Stock Market News Biopharmaceuticals

Posted on: 29/07/2024